Post-ASH 2021
News in the management of Castelman’s disease https://youtu.be/aLoaoGmr4is News and perspectives on the treatment of mastocytosis https://youtu.be/Ki-Q7FC67_c Thrombotic microangiopathies complicating carfilzomib therapy in myeloma https://youtu.be/a0zyjnXuLRo Paroxysmal nocturnal hemoglobinuria: C3 inhibitors arrive in 1L https://youtu.be/RhBtpbZhM-Y Clonal evolution in bone marrow aplasia: myth or reality? https://youtu.be/GSs_oC0hOlA Neurocognitive sequelae in patients with TTP: state of the art at ASH 2021 https://youtu.be/T0rfOQ017NY 1st results of JSP191, a humanized anti-CD117 antibody, in pre-transplant conditioning of patients with severe combined immune deficiency https://youtu.be/_5Gv_owkwJ0 30 years after G-CSF, a new oral treatment to antagonize neutropenia? https://youtu.be/rfNK69Czyas Treatment discontinuation and use during pregnancy of ARTPO in ITP https://youtu.be/gFc82xI4Z6w News and perspectives on the treatment of amyloidosis https://youtu.be/dmRLSmozQk4 Long-term follow-up of patients with Wiskott-aldrich syndrome treated with lentivirus-based gene therapies https://youtu.be/RjjFcIBGfl0 Efficacy of splenectomy in ITP in the era of ARTPO and ANTI-CD20 https://youtu.be/w2mFR-_Orjg Therapeutic management of amyloidosis: key lessons from real-life data https://youtu.be/_dRO02nL5dU